Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Granite Oil: Not Worth Your Money For Now

2018-08-20 seekingalpha - 1
Note: All figures are in USD unless otherwise stated. Granite Oil (OTCQX:GXOCF) trades primarily on the Toronto Stock Exchange as GXO.
GXOCF GXO GXE GENGF BTE

0
Investors Remain Skeptical Of Energy Stocks

2018-08-08 seekingalpha
The concerns started when OPEC+ announced that it would start increasing oil production scaring off the newcomers .
CRC MEG MEGEF GENGF GXE

1
Gear Energy Acquires Steppe Resources - An Accretive Acquisition

2018-07-31 seekingalpha
We believe, given Gear's track record of executing operationally, the Steppe acquisition could be highly accretive.
CPG SKX GENGF CPG GXE ENB

0
Gear Energy: Flexibility Will Further Improve Q2 Results

2018-07-17 seekingalpha
The only thing I am sure of about the next few weeks is that we should expect continued volatility, and a lot of it.
GENGF GXE

7
Enbridge's Line 3 Expansion Approval Offers A Nice Tailwind For Canadian Heavy Oil Producers

2018-06-29 seekingalpha
Minnesota PUC approved Enbridge's Line 3 expansion yesterday providing a bullish tailwind for Canadian heavy oil producers.
ENB CVE MEG CVE MEGEF GENGF GXE ENB

53
Raging River: Endure The Pain

2018-06-20 seekingalpha - 3
Raging River agreed to merge with Baytex for a small premium. After today’s selloff, the market is saying both are better at it alone.
BTE RRENF GXE GENGF PTORF SPE RRX

68
Unknown, Profitable, Oil-Weighted Energy Producer At Deep Discount To NAV And Peers

2018-05-23 seekingalpha - 2
Razor Energy is an oil-weighted energy producer that has increased its production significantly since 2017 while maintaining a strong balance sheet with leverage being well below 2 times.
BTE PGH CJ CRLFF CPG WCP YGR BNEFF VET SGY ZPTAF RRENF YGRAF RRX QTEYF GXOCF QEC TNEYF GENGF ATU CPG BNE RZREF GXO VET IPOOF GXE BTE SPGYF

4
The Positive Reflexive Feedback Loop Has Started For Energy Stocks

2018-05-21 seekingalpha
Energy sector performance relative to WTI has broken out of a downtrend that's been in place since the start of 2017.
CRC GENGF GXE

30
2018 Best Ideas Update - How Did We Do And Where They Are Headed

2018-05-11 seekingalpha
We give an update on our three best ideas of the year: California Resources, Gear Energy and Discovery Communications.
CRC DISCB DISCA GENGF GXE DISCK DISC

0
Gear Energy Ltd. Announces Results of Directors Vote

2018-05-09 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Gear Energy Ltd. (“Gear”) (TSX:GXE) is pleased to announce that the nominees listed in the management proxy circular dated April 2, 2018 were elected as directors of Gear. The detailed results of the vote for the election of directors held at Gear's annual meeting of shareholders held today (the “Meeting”) are set out below.
GXE GENGF

4
Weekly Oil Markets Recap - Outperformance Comes From Conviction And Patience

2018-05-06 seekingalpha
Not only is oil regaining multi-year highs, the HFI Portfolio and energy stocks are moving higher as well. As we wrote in a daily this week titled, "Leaderboard Change: Energy Stocks Climbing To The Top." There has been a not so subtle shift in the market leaderboard in April, and energy stocks are now climbing to the top.
CRC GENGF GXE

11
Using The Power Of Incentives To Understanding Markets And Oil

2018-05-04 seekingalpha
"Never, ever, think about something else when you should be thinking about the power of incentives." ~ Charlie Munger.
CRC GENGF GXE BXE

22
Open Square Fund Q1 2018 Commentary (Part 2 Of 2)

2018-04-19 seekingalpha
The market is currently distracted by the narratives of technology to the exclusion of other sectors.
CRC CDEV WLL GXE GENGF

4
Weekly Oil Markets Recap - Energy Stocks Aren't So Hated Anymore

2018-04-15 seekingalpha
Energy stocks have managed to outperform the broader markets by 9.8% since the middle of March, the steepest and fastest outperformance since the oil downturn.
CRC GENGF GXE

6
Buy Canadian Heavy Oil Producers As The WCS-WTI Discount Narrows

2018-04-03 seekingalpha
Canadian heavy oil producer equities have diverged greatly from the recent improvement in Western Canadian Select prices or WCS. The discount between WCS and WTI continues to narrow allowing knowledgeable investors to take advantage of the complacency in Canada.
KMI GENGF GXE KMR KMRFZ CVB

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...